Elsevier

Journal of Chromatography B

Volume 1090, 15 July 2018, Pages 65-72
Journal of Chromatography B

Bioavailability of wilforlide A in mice and its concentration determination using an HPLC-APCI-MS/MS method

https://doi.org/10.1016/j.jchromb.2018.05.018Get rights and content

Abstract

Wilforlide A (WA), an active compound in Tripterygium wilfordii Hook F (TW) which is a traditional Chinese medicine for treatment of autoimmune diseases, is a quality control marker for TW product. At present, the bioavailability/pharmacokinetics of WA is not known. Such information is not only essential to evaluate the relevance of WA as a quality control maker, but also important for future clinical efficacy studies. Therefore, a high-performance liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometric method (HPLC-APCI-MS/MS) was developed and applied to a bioavailability/pharmacokinetic study of WA.

WA and celastrol (the internal standard, IS) were extracted by a liquid-liquid extraction method using methyl tert-butyl ether. Multiple reaction monitoring (MRM) scanning in positive ionization mode was used to monitor the transition of m/z 455.1 to 191.3 for WA and 451.3 to 201.2 for IS. This method was validated and applied to a pharmacokinetic study of WA in mice following intravenous administration (IV, 1.2 mg/kg), intraperitoneal injection (IP, 6 mg/kg) and oral administration (PO, 30 mg/kg).

The lower limit of quantification (LLOQ) for WA was 10 ng/ml. The intra- and inter-day precision was found to be within 15.4% while the accuracy within 94.1–115.7% for all the quality control and LLOQ samples. The samples were stable under all the usual storage and experimental conditions. The terminal elimination half-lives were 14.7, 9.1 and 22.7 min following IV, IP and PO dosing, while the absolute bioavailability for IP and PO WA were 9.39% and 0.58% respectively.

These results indicated that the HPLC-APCI-MS/MS assay was suitable for the pharmacokinetic study of WA. WA was found poorly absorbed when given orally and therefore it may not be a relevant marker for the oral TW products in the market.

Introduction

Wilforlide A (WA) and triptolide are two active components in Tripterygium wilfordii Hook F (TW, also called Thunder God Vine), a traditional Chinese medicine (named Lei Gong Teng in Chinese) known for treatment of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus and psoriasis for years (Fig. 1) [[1], [2], [3]]. Currently, a product called Tripterygium wilfordii glycosides tablet or Lei Gong Teng Duo Gan Tablet is readily commercially available in China. In our previous study, the TW extract has also been found to sensitize prostate cancer resistant to docetaxel [4]. However, the use of TW extract has been associated with serious side effects such as immunosuppression and hepatotoxicity as well as quality control issues of herbal extracts [[5], [6], [7]]. Thus its active chemical markers, such as WA (content of 0.056 mg/g in root of TW) and triptolide (content of 0.067 mg/g to 0.8 mg/g in root of TW) would be attractive for further potential development [8,9]. Of the two chemical markers, triptolide has been reported to cause more side effects, such as immune suppression and anti-fertility than WA [10,11]. Its content is restricted to be no more than 10 μg per 10 mg (one tablet) in the commercial tablets [12]. In comparison, the recommended content of WA in the TW tablet is greater than 10 μg per 10 mg, consistent with a safer projection of this maker. In previous studies, WA has shown efficacious anti-inflammatory activities in carrageenan-induced rat pedal swelling and in tampon-induced rat granulation models with no significant immune suppressive effect [13]. Furthermore, we have observed an enhanced anticancer effect when combined with a conventional chemotherapeutic drug [14]. Thus, WA seems to be a good drug candidate to be further developed due to its various favorable activities, but less toxicity. However, there is no absorption and pharmacokinetic information available for WA. Such information will be useful for planning pre-clinical efficacy studies as well as future clinical trials in human subjects. In addition, the oral pharmacokinetic profile of WA will be relevant to its designation as a quality control marker for the TW product when given orally [15]. Therefore, in this study the bioavailability of WA following its oral and intraperitoneal administration is investigated using a newly developed high-performance liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometric assay (HPLC-APCI-MS/MS).

Section snippets

Materials and instruments

WA and celastrol were purchased from the National Institutes for Food and Drug Control (Beijing, China) with purities of greater than 95%. The analytical grade formic acid was obtained from Sigma-Aldrich Co. (St. Louis, MO, USA) with a purity of more than 99%. HPLC-grade methanol and acetonitrile were obtained from Fisher Scientific (Pittsburgh, PA, USA). Methyl tert-butyl ether (MTBE) was purchased from VWR International, LLC. (Brisbane, CA, USA). The blank mouse plasma (CD-1) was got from

Specificity and sensitivity

WA and celastrol were well separated under the chromatographic conditions without significant interference. The retention time of WA and celastrol was 10.3 and 9.2 min respectively (Fig. 3). This method was linear over the concentration range from 10 to 5000 ng/ml with R2 greater than 0.99. A1/x2 weighted linear regression was used for all calibration curves (x is the nominal concentration). The LOD and LLOQ of WA were identified to be 5 ng/ml and 10 ng/ml respectively, which indicated that

Discussion

In the present study, an assay method of WA was developed and applied to a bioavailability study in mice. Prior to our assay development, there was one previously published assay of WA which used a single quadrupole mass to detect WA using the Selected Ion Monitoring (SIM) mode by detecting the m/z of its molecular ion [17]. Since more than 300 components from Tripterygium wilfordii have been reported and many share similar chemical properties [1], a significant interference of the signal could

Conclusion

We have successfully developed and validated a simple, sensitive and accurate HPLC-APCI-MS/MS method suitable for the bioavailability/pharmacokinetic study of WA following IV, IP and PO dosing. The bioavailability of oral WA is extremely low (about 0.58%), which suggests that WA is not likely to be effective when given orally in human subjects. Thus, it may not be suitable to be a relevant active marker for quality control of Tripterygium wilfordii for oral administration.

Acknowledgements

This work was supported by a bridge fund of Western University of Health Sciences (M. Chow). We thank Dr. Yilong Zhang (Ph.D) for his input in the pharmacokinetic model analysis.

References (18)

There are more references available in the full text version of this article.

Cited by (13)

  • Wilforlide A ameliorates the progression of rheumatoid arthritis by inhibiting M1 macrophage polarization

    2022, Journal of Pharmacological Sciences
    Citation Excerpt :

    As Xue et al. suggested, the oral administration of Wilforlide A (300 μg/kg) in mice had significant anti-inflammatory effects.19 The bioavailability of Wilforlide A with intraperitoneal injection (9.39%) was better than oral supplement (0.58%).25 Thus, Wilforlide A at the dose of 30 μg/kg and 60 μg/kg was employed to CIA mice intraperitoneally every day from the 15th day after the first immunization in our study.

  • Selective and sensitive determination of celastrol in traditional Chinese medicine based on molecularly imprinted polymers modified Mn-doped ZnS quantum dots optosensing materials

    2020, Colloids and Surfaces B: Biointerfaces
    Citation Excerpt :

    Therefore, it is essential to accurately control the amount of Cel in traditional Chinese herbs, and develop the sensitive detection method of Cel in complex samples. Nowadays, some quality assessment methods for Cel have been widely reported, including HPLC [12], HPLC/MS [13–15], GC/MS [16,17]. These methods showed satisfactory sensitivity, but they have some problems, such as tedious sample pretreatment process, long detection time, complex and expensive instrument and so on.

  • Flow-cell radionuclide analysis

    2020, Handbook of Radioactivity Analysis: Volume 2: Radioanalytical Applications
  • Polymeric Membranes for Water and Wastewater Treatment

    2024, Membrane Technologies for Heavy Metal Removal from Water
View all citing articles on Scopus
View full text